COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions
COVID-19 Respiratory Infection
Interventions
DRUG

Vitamin D

Patients will be randomised to receive either high dose vitamin D (50,000 IU weekly) on the first and second week, followed by a switch to a daily intake of 5,000 IU for 3 months or low dose vitamin D (2,000 IU weekly) for 3 months.

Trial Locations (1)

194021

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health of the Russian Federation, Saint Petersburg

All Listed Sponsors
lead

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

OTHER

NCT05037253 - COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation | Biotech Hunter | Biotech Hunter